ECOG-ACRIN Biostatistics Center

The ECOG-ACRIN Biostatistics Center provides methodological expertise and leadership that is critical to the Group. Among its responsibilities, the Center oversees the data management and analysis of all ECOG-ACRIN studies. It operates from two locations. A team at the Dana-Farber/Harvard Cancer Center focuses on therapeutic studies while personnel at the Brown University School of Public Health direct their activities to medical imaging research. See the Locations and Contacts section at right.

Faculty and staff provide innovative solutions and integrate statistical science and effective data management into the clinical trials conducted by the Group. They possess deep experience and strengths in cancer diagnosis and therapy, as well as cancer control and outcomes, including surveillance research. They interact closely with executive leadership and researchers across ECOG-ACRIN. In addition, they participate in many other National Cancer Institute (NCI)-funded programs, including, but not limited to, other groups in the National Clinical Trials Network (NCTN) and the research bases in the NCI Community Oncology Research Program (NCORP).


The ECOG-ACRIN Biostatistics Center is co-led by Robert J. Gray, PhD (Harvard University) and Constantine A. Gatsonis, PhD (Brown University). They are two of the most experienced and respected biostatisticians in designing and implementing studies of cancer therapy and medical imaging, respectively, across the continuum of cancer care. Drs. Gray and Constantine participate in Group governance and all committees and administrative activities that involve the planning, implementation, and analysis of research studies.

Group Statistician, Therapeutics

Group Statistician,

Robert J. Gray, PhD

Dana-Farber Cancer Institute

Constantine A. Gatsonis, PhD

Brown University

ECOG-ACRIN Cancer Research Group